KBC GROUP NV – BioMarin Pharmaceutical Inc. Transaction History
KBC GROUP NV portfolio value:
$19.24M
portfolio value
KBC GROUP NV quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.38% | -877 shares | 359K | $84.77 | 226.96K |
Q2 2022 | share | Increase | +23.59% | 43.48K shares | 4.66M | $82.87 | 227.84K |
Q1 2022 | share | Decrease | -4.23% | -8.15K shares | -2.79M | $77.1 | 184.35K |
Q4 2021 | share | Decrease | -41.23% | -135.05K shares | -8.30M | $89.08 | 192.50K |
Q3 2021 | share | Increase | +40.14% | 93.82K shares | 5.81M | $77.29 | 327.56K |
Q2 2021 | share | Increase | +26.60% | 49.11K shares | 5.56M | $83.44 | 233.73K |
Q1 2021 | share | Increase | +28.11% | 40.50K shares | 1.30M | $75.51 | 184.62K |
Q4 2020 | share | Decrease | -28.24% | -56.71K shares | -2.64M | $87.69 | 144.12K |
Q3 2020 | share | Increase | +5.27% | 10.05K shares | -8.25M | $76.08 | 200.83K |
Q2 2020 | share | Increase | +96.07% | 93.48K shares | 15.30M | $123.34 | 190.78K |
Q1 2020 | share | Decrease | -39.08% | -62.42K shares | -5.28M | $84.5 | 97.30K |
Q4 2019 | share | Increase | +8.63% | 12.69K shares | 3.59M | $84.55 | 159.73K |
Q3 2019 | share | Increase | +22.58% | 27.08K shares | -364K | $67.4 | 147.03K |
Q2 2019 | share | Increase | +16.35% | 16.85K shares | 1.11M | $85.65 | 119.95K |
Q1 2019 | share | Decrease | -4.09% | -4.40K shares | 5K | $88.83 | 103.10K |
Q4 2018 | share | Decrease | -24.44% | -34.78K shares | -4.64M | $85.15 | 107.50K |
Q3 2018 | share | Increase | +245.40% | 101.08K shares | 9.91M | $96.97 | 142.28K |
Q2 2018 | share | Decrease | -84.99% | -233.20K shares | -18.36M | $94.2 | 41.19K |
Q1 2018 | share | Decrease | -12.69% | -39.87K shares | -5.77M | $81.07 | 274.39K |
Q4 2017 | share | Decrease | -14.34% | -52.60K shares | -6.12M | $89.17 | 314.27K |
Q3 2017 | share | Increase | +8.67% | 29.26K shares | 3.48M | $93.07 | 366.87K |
Q2 2017 | share | Increase | +18.56% | 52.84K shares | 5.66M | $90.82 | 337.60K |
Q1 2017 | share | Increase | +62.05% | 109.03K shares | 10.43M | $87.78 | 284.76K |
Q4 2016 | share | Increase | +102.29% | 88.85K shares | 6.52M | $82.84 | 175.72K |
Q3 2016 | share | Increase | +112.36% | 45.96K shares | 4.85M | $92.52 | 86.87K |
Q2 2016 | share | Increase | +5.26% | 2.04K shares | -22K | $77.8 | 40.90K |
Q1 2016 | share | Increase | +99.75% | 19.40K shares | 1.16M | $82.48 | 38.86K |